These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7674118)

  • 21. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif.
    Kreutter KD; Lu T; Lee L; Giardino EC; Patel S; Huang H; Xu G; Fitzgerald M; Haertlein BJ; Mohan V; Crysler C; Eisennagel S; Dasgupta M; McMillan M; Spurlino JC; Huebert ND; Maryanoff BE; Tomczuk BE; Damiano BP; Player MR
    Bioorg Med Chem Lett; 2008 May; 18(9):2865-70. PubMed ID: 18420408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of different anticoagulants on thrombin generation.
    Petros S; Siegemund T; Siegemund A; Engelmann L
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of dipeptides containing S-hexylcysteine.
    Bruzgo I; Midura-Nowaczek K
    Acta Pol Pharm; 2007; 64(5):479-82. PubMed ID: 18540170
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 27. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dracula's wish.
    Peters R; Sikorski R
    Science; 1999 May; 284(5418):1294. PubMed ID: 10383310
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.
    Lazarova TI; Jin L; Rynkiewicz M; Gorga JC; Bibbins F; Meyers HV; Babine R; Strickler J
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5022-7. PubMed ID: 16876411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity.
    Berry CN; Lassalle G; Lunven C; Altenburger JM; Guilbert F; Lalé A; Hérault JP; Lecoffre C; Pfersdorff C; Herbert JM; O'Connor SE
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1189-98. PubMed ID: 12438543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
    Zbinden KG; Obst-Sander U; Hilpert K; Kühne H; Banner DW; Böhm HJ; Stahl M; Ackermann J; Alig L; Weber L; Wessel HP; Riederer MA; Tschopp TB; Lavé T
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5344-52. PubMed ID: 16213138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysinosins B-D, inhibitors of factor VIIa and thrombin from the Australian sponge Lamellodysidea chlorea.
    Carroll AR; Buchanan MS; Edser A; Hyde E; Simpson M; Quinn RJ
    J Nat Prod; 2004 Aug; 67(8):1291-4. PubMed ID: 15332844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A laboratory method for parallel determination of platelet aggregation and thrombin generation.
    Köstenberger M; Gallistl S; Cvirn G; Muntean W
    Clin Lab; 2004; 50(1-2):41-8. PubMed ID: 15000219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo.
    He GX; Krawczyk SH; Swaminathan S; Shea RG; Dougherty JP; Terhorst T; Law VS; Griffin LC; Coutré S; Bischofberger N
    J Med Chem; 1998 Jun; 41(13):2234-42. PubMed ID: 9632356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkages.
    He GX; Williams JP; Postich MJ; Swaminathan S; Shea RG; Terhorst T; Law VS; Mao CT; Sueoka C; Coutré S; Bischofberger N
    J Med Chem; 1998 Oct; 41(22):4224-31. PubMed ID: 9784097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An anticoagulant with light-triggered antidote activity.
    Heckel A; Buff MC; Raddatz MS; Müller J; Pötzsch B; Mayer G
    Angew Chem Int Ed Engl; 2006 Oct; 45(40):6748-50. PubMed ID: 16983715
    [No Abstract]   [Full Text] [Related]  

  • 38. Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics.
    Hillisch A; Gericke KM; Allerheiligen S; Roehrig S; Schaefer M; Tersteegen A; Schulz S; Lienau P; Gnoth M; Puetter V; Hillig RC; Heitmeier S
    J Med Chem; 2020 Nov; 63(21):12574-12594. PubMed ID: 33108181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SR123781A, a synthetic heparin mimetic.
    Herbert JM; Hérault JP; Bernat A; Savi P; Schaeffer P; Driguez PA; Duchaussoy P; Petitou M
    Thromb Haemost; 2001 May; 85(5):852-60. PubMed ID: 11372679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of ximelagatran in an historical perspective.
    Gustafsson D
    Semin Vasc Med; 2005 Aug; 5(3):227-34. PubMed ID: 16123909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.